Provided by Tiger Trade Technology Pte. Ltd.

Bio-Rad Laboratories

294.90
-6.6000-2.19%
Post-market: 294.900.00000.00%19:10 EST
Volume:256.27K
Turnover:75.30M
Market Cap:7.95B
PE:-12.01
High:299.11
Open:298.17
Low:287.59
Close:301.50
52wk High:345.70
52wk Low:211.43
Shares:26.97M
Float Shares:18.51M
Volume Ratio:1.09
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-24.5614
EPS(LYR):-65.3647
ROE:-9.50%
ROA:1.57%
PB:1.18
PE(LYR):-4.51

Loading ...

Earning Preview: Bio-Rad Laboratories Q4 revenue is expected to increase by 2.16%, and institutional views are cautious

Earnings Agent
·
Feb 05

Horizon Space Updates Proxy for SL BIO Merger Vote

TIPRANKS
·
Feb 07

SAB BIO to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Feb 04

Bio-Rad Laboratories Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Jan 29

Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026

THOMSON REUTERS
·
Jan 29

BIO-key EMEA Subsidiary Partners with Citadel Global to Expand India Presence and Accelerate Adoption of Biometric Identity Solutions in Support of EU–India Free Trade Agreement

GlobeNewswire
·
Jan 29

BIO-key announces strategic partnership with Visualforma

TIPRANKS
·
Jan 28

Bell Potter Keeps Their Buy Rating on Biome Australia Ltd (BIO)

TIPRANKS
·
Jan 28

KALA BIO Receives Nasdaq Notice on Listing Compliance

TIPRANKS
·
Jan 24

Qiagen Explores Possible Sale After New Buyer Talks: Report

Benzinga_recent_news
·
Jan 21

Lendable Breaks New Ground in Impact Fund Raise

prnewswire
·
Jan 21

Horizon Space Updates Proxy Materials for SL BIO Merger

TIPRANKS
·
Jan 16

Dalian BIO-CHEM Elects Chair

MT Newswires Live
·
Jan 15

SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination

GlobeNewswire
·
Jan 14

KALA BIO Launches At-the-Market Equity Offering Program

TIPRANKS
·
Jan 09

Press Release: SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

Dow Jones
·
Jan 07

Bio-Rad Laboratories Executives Meet Investors at J.P. Morgan Healthcare Conference

Reuters
·
Jan 06

New crypto tokens are failing in 2025: 85% below TGE prices

cryptonews
·
Dec 21, 2025

First Patient Dosed in SAB BIO’s SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D

GlobeNewswire
·
Dec 18, 2025

SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D

GlobeNewswire
·
Dec 17, 2025